tiprankstipranks
Advertisement
Advertisement

AU:LTP Stock Latest News

LTR Pharma issues cautionary investor update on non-offer presentation
Company AnnouncementsLTR Pharma issues cautionary investor update on non-offer presentation
21d ago
LTP
LTR Pharma completes recruitment for key Phase II SPONTAN study
PremiumCompany Announcements
LTR Pharma completes recruitment for key Phase II SPONTAN study
27d ago
LTP
LTR Pharma lodges half-year Appendix 4D report with ASX
PremiumCompany Announcements
LTR Pharma lodges half-year Appendix 4D report with ASX
1M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
PremiumCompany Announcements
LTR Pharma Seeks ASX Quotation for Additional 50,000 Shares
2M ago
LTP
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
PremiumCompany Announcements
LTR Pharma Advances ED Nasal Spray Programs as SPONTAN Use Tops 1,000 Prescriptions
2M ago
LTP
LTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany AnnouncementsLTR Pharma Begins Phase II Dosing for Intranasal Erectile Dysfunction Spray SPONTAN
2M ago
LTP
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
Premium
Company Announcements
LTR Pharma Seeks ASX Quotation for Additional 82,508 Shares
2M ago
LTP
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
Premium
Company Announcements
LTR Pharma Issues 8.3 Million Unquoted Options Expiring in 2028
3M ago
LTP
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
PremiumCompany Announcements
LTR Pharma Begins Phase II Recruitment for Intranasal Erectile Dysfunction Spray SPONTAN
3M ago
LTP
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
PremiumCompany Announcements
LTR Pharma’s SPONTAN Nasal Spray Data Wins Podium Slot at 2026 Sexual Medicine Congress
3M ago
LTP
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
PremiumCompany Announcements
LTR Pharma Issues New Unquoted Performance Rights and Options Under Incentive Schemes
3M ago
LTP
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
PremiumCompany Announcements
LTR Pharma Achieves Milestone with SPONTAN® Prescriptions
4M ago
LTP
LTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
PremiumCompany AnnouncementsLTR Pharma Receives TGA Clearance for SPONTAN® Phase II Study
4M ago
LTP
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
Premium
Company Announcements
LTR Pharma Advances SPONTAN® Phase II Clinical Study with Ethics Approval
4M ago
LTP
LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
Premium
Company Announcements
LTR Pharma to Release Securities from ASX Escrow, Enhancing Market Liquidity
4M ago
LTP
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
PremiumCompany Announcements
LTR Pharma Director Acquires 1 Million Options Under Incentive Plan
4M ago
LTP
LTR Pharma Limited Announces Change in Director’s Interest
PremiumCompany Announcements
LTR Pharma Limited Announces Change in Director’s Interest
4M ago
LTP
LTR Pharma Announces Director’s Interest Change
PremiumCompany Announcements
LTR Pharma Announces Director’s Interest Change
4M ago
LTP
LTR Pharma Issues Unquoted Equity Securities for Employee Incentive
PremiumCompany Announcements
LTR Pharma Issues Unquoted Equity Securities for Employee Incentive
4M ago
LTP
LTR Pharma Advances US Market Entry with Strategic Appointments and Validations
PremiumCompany AnnouncementsLTR Pharma Advances US Market Entry with Strategic Appointments and Validations
5M ago
LTP
LTR Pharma Achieves Unanimous Resolution Approval at 2025 AGM
Premium
Company Announcements
LTR Pharma Achieves Unanimous Resolution Approval at 2025 AGM
5M ago
LTP
LTR Pharma Expands Global Footprint with Innovative Therapies
Premium
Company Announcements
LTR Pharma Expands Global Footprint with Innovative Therapies
5M ago
LTP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >